Lannett Eyes Insulins Opportunity And Advances Respiratory Assets

CEO Tim Crew Sets Out Expectations For Pipeline As Firm Licenses Insulin Pen Patent

 
• By Dave Wallace
  
Insulins vials red yellow
Insulin glargine and insulin aspart are two of Lannett’s major pipeline assets • Source: Shutterstock

More from Strategy

More from Business